gentian violet has been researched along with Angioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbiser, JL; Bhandarkar, SS; Brown, LF; Carrillo, CO; Cerimele, F; Dumont, D; Govindarajan, B; Ioffe, E; Knaus, UG; Losken, A; Perry, BN; Sohn, A; Sturk, C; Tan, X; Valo, M; Williams, J; Yancopoulos, GD | 1 |
1 other study(ies) available for gentian violet and Angioma
| Article | Year |
|---|---|
Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice.
Topics: Angiopoietin-2; Animals; Gentian Violet; Hemangioma; Humans; Mice; NADPH Oxidases; Quaternary Ammonium Compounds; Receptor, TIE-2; RNA, Messenger; Signal Transduction | 2006 |